Harmonic Pharma DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Enforcement Report - Week of October 29, 2025

29 Oct 2025

// FDA

Innovent's Mazdutide Outperforms Semaglutide In Glycemic Control

28 Oct 2025

// PR NEWSWIRE

Curia Invests $4 Million To Enhance Sterile API Manufacturing

28 Oct 2025

// GLOBENEWSWIRE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

ACI Convention

Not Confirmed

Book a meeting

envelop Contact Supplier

Latest Content

radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

About

Harmonic Pharma has been founded in 2009 with a core technology dedicated to drug repurposing. The company has developed a platform to investigate the mechanism of action of any type of chemicals over the last years. Complementary AI-based solutions have been developed through the dual program entitled Chemical Range to provide public and private organizations with a more comprehensive toxicity profiling. December 2017, Seqens group announced his support to Harmonic Pharma through a capital increase. According to Pierre Luzeau, President of Seqens : “The access to Harmonic Pharma’s technology broadens Seqens’ services.